Skip to main content

Zura Bio Ltd

ZURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001855644

No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Zura Bio Ltd changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ZURA: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders1725+8
Shares3.21M4.91M+1.70M (+53.0%)
Value$31.6M$48.5M+$16.9M (+53.6%)

New holders (11)

Institutions that held Zura Bio Ltd at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ZURA in Q4 2021
InstitutionSharesValue% of portfolio
Owl Creek Asset Management, L.P.450,000$4.44M0.30%
Marshall Wace, LLP281,520$2.78M0.01%
Whitebox Advisors LLC150,000$1.48M0.03%
Prelude Capital Management, LLC150,000$1.48M0.07%
Angelo Gordon & Co., L.P.136,694$1.35M0.13%
Millennium Management LLC130,000$1.28M0.00%
Picton Mahoney Asset Management100,000$988.0K0.04%
Lombard Odier Asset Management (USA) Corp100,000$987.0K0.15%
D. E. Shaw & Co., Inc.88,597$874.0K0.00%
HRT Financial LP49,000$483.0K0.00%
Dark Forest Capital Management LP3,800$38.0K0.01%

Sold out (3)

Institutions that held Zura Bio Ltd at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ZURA in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Oaktree Capital Management LPSuperinvestorOaktree Capital150,000$1.47M
Highland Capital Management Fund Advisors, L.P.31,000$306.0K
Wolverine Asset Management LLC105$1.00K